Villejuif (1)

Cancer With POLE Exonucleasic Domain Mutation (1)

Carcinoma, Renal Cell (1)

Head and Neck Neoplasm (1)

Microsatellite Instability (1)

Penile Neoplasms (1)

Skin Neoplasms (1)

Active, not recruiting (1)

phase 2 (1)

UNICANCER (1)

Bristol-Myers Squibb (1)

Ligue contre le cancer, France (1)

National Cancer Institute, France (1)

nivolumab (1)

drug (1)

Other (1)

Interventional (1)

cancer with pole exonucleasic domain mutation

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Mar 28, 2022